8/23/2021 | 11:45 AM to 1:30 PM
Chronic Diseases, Health Conditions and Risk of covid-19-related Hospitalization and In-hospital Mortality During the First Wave of the Epidemic in France: A Cohort Study of 66 Million People
Objectives: To determine medical and socioeconomic risk factors associated with risks of COVID-19-related hospitalization and in-hospital mortality in the entire French country.
Methods: In France, the SNDS healthcare database was used to estimate the risk associated with about fifty diseases or health conditions, for hospitalization primarily related to COVID-19 and COVID-19-related deaths among all people alive on February 15. Cox proportional hazards models were used to estimate hazard ratios (HR) after adjustment for age and gender, and then in models including all variables (adjusted hazard ratios [aHR]).
Results: In a population of 66,050,090 people, 87,809 people (134 per 100,000) were hospitalized for COVID-19 between February 15, 2020 and June 15, 2020 and a subgroup of 15,661 people (24 per 100,000) died in hospital. A much higher risk was observed with increasing age. Men were at higher risk compared to women. Almost all chronic health conditions were positively associated with an increased risk of COVID-19-related hospitalization and in-hospital mortality, with the exception of dyslipidaemia, which was negatively associated. The strongest associations for both COVID-19-related hospitalization and in-hospital mortality were observed in people with Down syndrome (aHR, 7.0 [6.1-8.1] and 22.9 [17.1-30.7], respectively), mental retardation (3.8 [3.5-4.2] and 7.3 [6.1-8.8]), kidney transplantation (4.6 [4.2-5.0] and 7.1 [6.0-8.4]), lung transplantation (3.5 [2.4-5.3] and 6.2 [2.8-14.0]) end-stage renal disease on dialysis (4.2 [3.9-4.4] and 4.7 [4.2-5.2]) and active lung cancer (2.6 [2.4-2.8] and 4.0 [3.5-4.6]). Stratified analyses showed stronger associations in patients under the age of 80 years between the risks for severe forms of COVID-19 and certain chronic diseases such as diabetes or cancer. Strong associations between social deprivation index and risk of COVID-19 were observed in people under the age of 80 years with a twofold higher risk of death among the most deprived compared to the least deprived.
Conclusions: This national cohort study confirms the associations with most diseases and health conditions in France and provides data on less frequent health conditions, which could be useful particularly to target priority populations during present and future vaccination campaigns.
Authors
Speakers
Mahmoud Zureik
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance)
Laura Semenzato
EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Jérémie Botton
EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Jérôme Drouin
EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
François Cuenot
EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance
Rosemary Dray-Spira
EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products [ANSM], and French National Health Insurance [CNAM]), Saint-Denis, France
Alain Weill
French National Health Insurance Fund (Assurance Maladie)
COVID-19 Epidemiology: Risk Factors, Drug Exposures, and Outcomes
Category
General Sessions
Description
Presenting Author
Mahmoud Zureik
| EPI-PHARE, Epidemiology of Health Products (French National Agency for the Safety of Medicines and Health Products, and French National Health Insurance)